Robinhood stock slips as venture fund tees up $1 billion IPO roadshow

February 17, 2026
Robinhood stock slips as venture fund tees up $1 billion IPO roadshow

NEW YORK, Feb 17, 2026, 10:58 EST — Regular session

  • Robinhood shares slipped as U.S. markets kicked back into gear after the long weekend.
  • Robinhood Ventures Fund I, which is backed by the company, has started IPO marketing before its expected debut on the NYSE.
  • Eyes are on a company webcast set for later Tuesday, with traders also tracking the next move in crypto prices.

Shares of Robinhood Markets (HOOD.O) slipped 1.7% to $74.67 Tuesday morning.

Shares shifted after the company announced that Robinhood Ventures Fund I has kicked off its roadshow, the typical pre-IPO marketing blitz, aiming for a debut on the New York Stock Exchange.

Robinhood’s fund isn’t part of the main brokerage operation, but it adds another offering just as investors are pressing the company on how much future growth can rely on sources beyond crypto-fueled trading surges.

Robinhood Ventures Fund I is looking to offload 40 million shares, pricing them around $25 each. Of that total, 35 million shares will come directly from the fund itself, while Robinhood steps in as the selling shareholder for the remaining 5 million. Underwriters also get a 30-day window to snap up as many as 6 million additional shares.

The company said its shares should debut on the NYSE under the ticker RVI, with Goldman Sachs acting as the only bookrunner.

Crypto held attention. Bitcoin edged down 0.2% to roughly $67,336; Coinbase shares, though, picked up 1.2% over the same period.

After being closed for Presidents Day, U.S. markets were back in action Tuesday.

Robinhood posted record revenue in its latest quarterly report last week, but the numbers came in shy of estimates as crypto trading pulled back. “The active traders were still really active,” finance chief Shiv Verma told Reuters then, though he noted many were using the platform’s lower pricing tiers. Reuters

Yet the venture-fund launch isn’t locked in just yet. According to the fund’s SEC filing, shares can’t be sold until the registration statement is declared effective. The document also flags a common pitfall: closed-end funds frequently trade below their net asset value—the value of what’s held per share—posing a risk for anyone looking to jump in and out quickly.

Coming up at 1 p.m. ET on Tuesday, Robinhood Markets is putting CEO Vlad Tenev, CFO Shiv Verma and the fund’s president on a livestream. It’s the official roadshow kickoff—investors will be tuned in, looking for details on timing, fees, and just how this venture product slots into Robinhood’s bigger ambitions outside of trading commissions.

Technology News Today

  • Big Pharma bets big on quantum computing to accelerate drug discovery
    April 10, 2026, 2:26 PM EDT. Big pharma is moving into the quantum computing arena as funding climbs and partnerships sharpen. Quantum machines use qubits, which can occupy multiple states at once, potentially solving drug-discovery problems beyond today's classical computers. Tech giants tout speed advantages, while pharma groups test the approach with startups and service firms. Boehringer Ingelheim teamed with Google Quantum AI; Pfizer linked with XtalPi; Amgen partnered with Quantinuum, born from Honeywell's quantum unit. VC activity flooded in during 2025, totaling about $3.8 billion in deals, with another $581 million early in 2026. The industry pursues "quantum supremacy"-the moment a quantum computer outperforms the strongest classical machines-while investors and researchers push toward practical milestones in computational biology.